SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC
Clinical trial NCT06457906 · RECRUITING
Trial details
- NCT number
- NCT06457906
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2027-08-30
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.